Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$323,867
+$314,347 QoQ
Shares Held
652
+3004.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,177
of 1,705 holders
Holding Since
Jun 2021
8 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Optiver Holding B.V. holds $14,290,859 across 180 Biotechnology names. VRTX ranks #4 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
76,368 | $10,176,799 | |
| 2 | TECH |
BIO-TECHNE Corp
|
8,493 | $600,030 | |
| 3 | NBTX |
Nanobiotix S.A.
|
13,631 | $513,888 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
652 | $323,867 | |
| 5 | BNTX |
BioNTech SE
|
2,150 | $200,057 | |
| 6 | IBRX |
ImmunityBio, Inc.
|
22,559 | $197,504 | |
| 7 | ARGX |
Argenx SE
|
174 | $161,431 | |
| 8 | VNDA |
Vanda Pharmaceuticals Inc.
|
18,089 | $110,704 |
All Filings in VRTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $323,867 | 652 | Shares | Defined | 2026-08-12 | |
| 2025-12-31 | $9,520 | 21 | Shares | Defined | 2026-02-17 | |
| 2025-03-31 | $13,090 | 27 | Shares | Defined | 2025-05-15 | |
| 2024-03-31 | $158,007 | 378 | Shares | Defined | 2024-05-09 | |
| 2022-09-30 | $9,265 | 32 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $12,736 | 58 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $10,520 | 58 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $18,348 | 91 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||